RESOURCES FROM GENETEX
Poster Download: Inflammasomes in Neurological Disorders by GeneTex
Inflammasomes are intracellular protein complexes that act as sensors for danger signals. They typically consist of a sensor protein (from the NLR, ALR, or pyrin families), an adaptor protein (ASC), and procaspase-1. Upon detecting a specific trigger, the sensor protein assembles the complex, leading to the activation of caspase-1 [2]. Active caspase-1 then drives inflammation by:
- Cleaving pro-cytokines into active IL-1β and IL-18.
- Cleaving gasdermin D (GSDMD) to induce a lytic, pro-inflammatory cell death called pyroptosis.
The NLRP3 inflammasome is the most studied and requires a two-step activation: a “priming” signal, often from TLR signalling, to increase expression of inflammasome components, followed by an “activation” signal to trigger assembly [2].
Inflammasome activation, particularly the NLRP3 inflammasome, can be linked to several neurological conditions and sepsis, for example:
- Alzheimer’s Disease (AD)
- Amyotrophic Lateral Sclerosis (ALS)
- Multiple Sclerosis (MS)
- Parkinson’s Disease (PD)
- Stroke
- Traumatic Brain Injury (TBI)
- Epilepsy
- Sepsis
GeneTex is proud to offer a catalogue of antibody reagents to facilitate your research in inflammasomes in neurological disorders. Just simply download the poster here to read more.
Keywords: disease modelling, drug discovery, pharmacology research, drug screening, proteomics, neurodegeneration, immunology, histology, IHC, flow cytometry
References:
1. Poster: GeneTex. ”Inflammasomes in Neurological Disorders”. Available at: https://www.genetex.com/upload/media/resources/Download%20Literature/Posters/Download/GeneTex_Inflammasomes-in-Neurological-Disorders-poster_300dpi.pdf
2. Article: Voet, Sofie et al. “Inflammasomes in neuroinflammatory and neurodegenerative diseases.” EMBO molecular medicine vol. 11,6 (2019): e10248. doi:10.15252/emmm.201810248
All products listed on this site and sold through LAB-A-PORTER Limited are for research use only (RUO). Not for human use. Not for therapeutic or diagnostic use.
ABOUT GENETEX
With a 27-year production history, GeneTex continues to distinguish itself by emphasizing reagent validation.
Founded by scientists for scientists, GeneTex understands that researchers expect and demand product fidelity.
With a 27-year production history, GeneTex distinguishes itself by emphasising reagent validation. Poorly characterized antibodies remain an industry-wide challenge that impacts progress in the life sciences and biomedicine.
At GeneTex, product reliability is their primary concern. Stringent protocols have been established to validate their antibodies for various applications, including WB, IP, IHC, ICC/IF, FACS, and ELISA, using cell lines with known target protein expression levels and a diverse array of tissue samples. Lot-to-lot antibody performance is maintained through a combination of fully characterized reference lots, clone verification, and thorough quality control.
GeneTex products are made to standards outlined in quality management systems ISO 9001:2015, ISO 13485:2016 and ISO 14001: 2015.
Featured antibodies
Featured GeneTex antibodies in cancer research, neuroscience research, infectious diseases research, immunology research, metabolism research, as well as zebrafish-validated antibodies, Drosophila-validated antibodies, cell markers etc.
All products listed on this site and sold through LAB-A-PORTER Limited are for research use only (RUO). Not for human use. Not for therapeutic or diagnostic use.